Skip to main content

Presentations

Presentations

    • Du Vall SL. Big Data and the VA Informatics and Computing Infrastructure. University of Maryland, Baltimore County Center for Hybrid Multicore Productivity Research (CHMPR) Semi-Annual Industry Advisory Board Meeting. Baltimore, MD; December 18, 2012.
    • Brixner DI. Personalize Health Care November 26, 2012 Meeting.[Presentation] Panel Discussion: Outcomes and Cost Effectiveness inPersonalized Health Care. University of Utah, Salt Lake City, UT. November 26, 2012.
    • Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell ES, Saag KG, Safford MM, DuVall SL, Alexander K, Napalkov P, Kamauu AWC, Baddley J. Hospitalized Bacterial Infections Among U.S. Veterans with Rheumatoid Arthritis Initiating TNF Antagonist and Newer Biologic Agents. ACR / ARHP 2012 Annual Scientific Meeting, Washington, DC; November 10-14, 2012.
    • DuVall SL. VINCI: A convergence of policy and technology for enabling big data analytics in the Department of Veterans Affairs. IBM Canada Software Laboratory Centre for Advanced Studies Research 22nd Annual International Conference, Toronto, Canada; November 5-7, 2012.
    • Bellows BK, McAdam-Marx C, Unni S, Ye X, Mukherjee J, Brixner DI. 12-month HbA1c and weight outcomes by drug class in treatment native patients with type 2 diabetes. Meeting in the Middle Western Pharmacoeconomic Conference. Austin, TX. June 22-24, 2012.
    • Stevens V. Pharmacologic Risk Factors for Clostridium difficile Infection (CDI). Salt Lake City Veterans Affairs Informatics, Decision Enhancement, and Surveillance (IDEAS) Center, Salt Lake City, Utah. 2012.
    • Stevens V. Clostridium difficile Infections in Adult and Pediatric Patients. Pediatric Infectious Disease Division Meeting, University of Utah, Salt Lake City, UT. 2012.
    • LaFleur J, Smith J, Nelson S, Nelson R, Adler RA, Nebeker JR, Malone DC. Cost-effectiveness analysis of different strategies for fragility fracture prevention in United States veterans. Value in Health;15(4):A8. International Society for Pharmacoeconomics and Outcomes Research 17th International Meeting. Washington, DC. June 4, 2012.
    • Ghate SR, Brixner DI. Predictors of Monitoring of Metabolic Parameters in Adolescents on Antipsychotics. Presentation at the 2012 APA Annual Meeting, Philadelphia, PA. May 5-9, 2012.
    • Brixner DI. Department of Family and Preventive Medicine Grand Rounds. Decision Modeling, Outcomes Research and Health Technology Assessment: Experiences from my Austrian Sabbatical. University of Utah, Salt Lake City, UT. May 3, 2012.
    • Ghate SR, Said Q, Brixner DI, Hashibe M, Joy E, Porucznik CA. "Comparison of the Trend in Prevalence of Overweight Among Adolescents on Antipsychotics to Non-Users from 2000 to 2009." Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14-17 2011.
    • Brixner D, Biskupiak J. "Application of Real World Databases In the U.S."; AGENS meeting (Working Group on the Use of Secondary Data) University for Health Sciences, Medical Informatics and Technology; Hall in Tirol, July 22, 2011.
    • LaFleur J, Nelson RE, Hayden C, Reimer L, Kone K, Nebeker J. Fewer than a quarter of HIV-positive Veterans adhere to medications at recommended levels. Veterans Affairs Health Services Research and Development (HSR&D) 2011 National Meeting. Baltimore, Maryland. February 2011.
    • Brixner D, Kwong WJ, Ghate S, Biskupiak J, Ye X. Cost Of Warfarin-Associated Bleeding In Atrial Fibrillation. Presented at the Academy of Managed Care Pharmacy, Minnesota, MN. April 27-30, 2011.
    • Biskupiak J, McAdam Marx C, Hane CA, Deniz B, McGarry L, Brixner D. Costs Associated with HCV and Related Complications in the United States from a Managed Care Payer's Perspective. ISPOR 16th Annual International Meeting. Baltimore, Maryland. May 2011. Recipient of the "Best General Podium Presentations" award.
    • Brixner DI Evaluation of Support Services to Colorectal Cancer Patients in Mexico[Poster Presentation] ISPOR 13th Annual European Congress Prague, Czech Republic November, 2010.
    • Brixner DI Current and Future Use of Pharmacoeconomic and Outcomes Research Data in Decision Making in the USA. [Poster Presentation] ISPOR 13th Annual European Congress Prague, Czech Republic November, 2010.
    • Brixner DI, Future Trends in Using HEOR Data in Formulary Decision Making [Round-Table] AMCP 2010 Educational Conference St. Louis, Missouri. October, 2010.
    • Brixner DI, Major Challenges and Opportunities for Managed Care Pharmacy [Symposium] AMCP 2010 Educational Conference St. Louis Missouri October, 2010.
    • Asche CV, Kim J, Chakravarti P, Kulkarni A, Andersson K. "Assessment of Increased Heart Rate to Cardiovascular (CV) Events among Healthy Subjects: An Electronic Medical Record (EMR) Data Analysis" The 23rd Scientific Meeting of the International Society of Hypertension (ISH), Vancouver, British Columbia, 2010, Sept, 26-30, 2010.
    • Brixner, DI. Oderda G, Healthcare and Economics - Educating researchers and health-care policy makers regarding the value of providing medicines. Asian Health Economics Training Workshop Jakarta, Indonesia Sept. 2010.
    • Brixner, DI. Oderda G, Application of Economic Evaluation Tools from the United States and Europe Toward Pricing and Reimbursement Stategies in the Asia-Pacific Region. ISPOR 4th Asia-Pacific Conference. Phuket, Thailand August, 2010.
    • Brixner DI, Oderda G, Application towards Integrated Learning of the Medical Pipeline in the PharmD Curriculum. AACP Annual Meeting: Expanding Our Horizons. Seattle, WA, July 2010.
    • Brixner DI, Biskupiak J, Holtorf AP. Current and future use of health economic and outcomes research data in decision making European Society of Medical Decision Making Workshop. Hall In Tyrol, Austria May 31, 2010.
    • Brixner DI. U.S. Primary Care Practice Electronic Medical Record Database: GE Centricity. [Short Course] ISPOR 15th Annual International Meeting. Atlanta, GA. May, 2010.
    • Brixner DI, Parkinson J, Eaddy M. Applications In Using Large Databases. ISPOR 15th Annual International Meeting. Atlanta, GA. May, 2010.
    • Brixner DI. "Healthcare and Economics" Educating researchers and healthcare policy makers regarding the value of providing medicines. 2nd Global Health Care Summit - Dubai, UAE May 4, 2010.
    • Brixner DI, Comparing Adherence Measures Against One-Year Outcomes for Patients with Epilepsy. AMCP 22nd Annual Meeting & Showcase. San Diego, CA. April, 2010.
    • Nickman NA. Impact of new technologies on the future of pharmacy practice. DUPHAT 2010 Dubai International Pharmaceuticals and Technologies Conference and Exhibition. Dubai, United Arab Emirates; 2010 March 16.
    • Brixner DI, Oderda G. "Healthcare and Economics" - Educating researchers and health-care policy makers regarding the value of providing medicines. Asian Health Economics Training Workshop - Jakarta, Indonesia. Jan. 14, 2010.
    • McAdam-Marx C. Late Phase Development of an Antidiabetic Treatment: A Case Study. Late Phase Drug Development World 2009. December 3, 2009. London,UK.
    • Nickman NA. Professional skills development in future pharmacists: a world-wide issue. DUPHAT 2009 Dubai International Pharmaceuticals and Technologies Conference and Exhibition. Dubai, United Arab Emirates. March 2009.
    • Oderda GM. Naresuan University. Pharmacoeconomics. Phitsanulok, Thailand. March 2009.
    • LaFleur J. "Clinical risk factors for fracture: Applying research to knowledge-engineering for decision support" [keynote speech]. University of Utah, Division of Geriatrics and Veterans Affairs Salt Lake City Geriatric Research, Education and Clinical Center (GRECC) Geriatric Research Conference. Salt Lake City, Utah. February 2009.
    • Brixner DI. Guidelines for Research Using "Real World Data". Enhancing the Rigor and Utility of Medication Use Research A Consensus Development Conference. Rockville, MD. January 2009 Co-sponsored by AACP, PPRA, ISPOR and USP.
    • Brixner, DI, McAdam-Marx, C, Ye, XY, Boye, K, Fabunmi, R, Schroeder, B. Real World Six Month Outcomes of Patients Initiating Exenatide in a Primary Care Electronic Medical Record Database. 13th Annual International Meeting International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, Canada, May, 2008.
    • Asche CV, Jacobs P, Yim R. Economic databases for pharmacoeconomic evaluations in Canada: Overview and use. 13th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Toronto, Canada, May 2008.
    • Ghate SR, Said Q, Rosenblatt LC, Kim E, Pikalov A, Brixner DI. Real World Association between Antipsychotic Treatment and Weight Gain in an Adolescent Population. International Society of Pharmacoeconomics and Outcomes Research 13th Annual International Meeting (ISPOR), Toronto Canada, May 2008.
    • Brixner DI, Ghate SR, McAdam-Marx C, Maio V. Analysis of Prescribing Patterns of Antihypertensive Agents (AA) Before and After Publication of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 1st Latin America Conference, Cartagena, Columbia, 2007.
    • Brixner DI, Jackson K, Sheng X, Biskupiak J, Keskinaslan A. Compliance with Multiple Combination Antihypertensive Pharmacotherapy in a Large US Database. ISPOR 10th Annual European Congress, Dublin, Ireland, 2007.
    • Said Q, Ghate SR, McAdam-Marx C, Brixner DI. Correlation of weight to cardiometabolic risk as identified by ICD-9 diagnosis codes and prescriptions in primary care. ISPOR 12th Annual International Meeting, Arlington, VA.
    • LaFleur J, McAdam-Marx C, Asche CV, Alder S, Sheng X, Brixner DI, Silverman S. The risk of clinical vertebral fracture for postmenopausal patients with specific combinations of fracture risk Factors in a primary-care setting. [Poster] National Osteoporosis Foundation, 7th International Symposium on Osteoporosis: Translating Research into Clinical Practice, Washington, DC.
    • Brixner DI. The Differences Between RCTs and �Real World� Studies. Real World Data and the Formulary Decision Process: Bridging the Gap, San Diego, CA.
    • Said Q, Gutterman E, Kim M, L'Italien G, Chi-Chang C, Whitehead R, Brixner DI. The Association Between Antipsychotic Treatment and Unintentional Injury in Patients Diagnosed with Psychiatric Disorder. 2007 International Congress on Schizophrenia Research, Colorado Springs, CO / American Psychiatric Association Annual Meeting, San Diego, CA.
    • McAdam-Marx C, Brixner DI, Metrau S, Chan V, Field R. Determinants of Race and Ethnicity Reporting for Youth with Health Data in an Electronic Medical Record Database. Fifth Annual University of Sciences in Philadelphia Scholarly Day, Philadelphia, PA.
    • Brixner DI, Magowan S, Accortt N. Evaluation of Prescription Refill Patterns Based on Daily Dosing Regimen and Pill Load for Calcium Channel Blockers. Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA.
    • Brixner DI, Oderda G, Kirkness C, Said Q. Assessment of Cardiometabolic Risk in a National Primary Care Electronic Medical Database (EMR). Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA.
    • Brixner DI. The Prevalence and Burden of Migraine and Its Impact on Managed Care. Academy of Managed Care Pharmacy 19th Annual Meeting and Showcase, San Diego, CA.
    • Asche CV, Young D, Brixner DI, Phillips A. Assessment of Physician Prescribing for Primary Care Patients with Chronic Obstructive Pulmonary Disease (COPD) in a National Electronic Medical Record (EMR) Research Database. American College of Clinical Pharmacy (ACCP) 2007 Spring Practice and Research Forum, Memphis, TN.
    • Asche CV, Machado M, Caro J. ISPOR Digest of International Databases for Pharmacoeconomics and Outcomes Research. 1st Annual Latin American Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Cartagena, Columbia, 2007.
    • Asche CV, Cummings G. ISPOR Digest of international databases for pharmacoeconomics and outcomes research. 10th Annual European Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Dublin, Ireland, 2007.
    • Oderda G, Lieberman M, Asche CV, Brixner DI. Use of electronic medical record (EMR) data in outcomes research. 10th Annual European Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Dublin, Ireland, 2007.
    • Asche CV, Seal B, McAdam-Marx C, Crookston B, Svejda R, Mullins CD. Treatment costs associated with community acquired pneumonia by community level of antimicrobial resistance. 10th Annual European Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Dublin, Ireland, 2007.
    • LaFleur J, McAdam-Marx C, Asche CV, Alder S, Sheng X, Brixner DI, Silverman S. Clinical risk factors for fracture are additive in postmenopausal women who are at risk for fracture in a primary care setting. American Society for Bone and Mineral Research (ASBMR) 29th Annual Meeting, Honolulu, Hawaii, 2007.
    • Asche CV, Brixner DI, L'Italien GJ. Pharmacoeconomic Research in Latin America: Gathering the Data for Dossier Requirements. 1st Annual Latin American Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Cartagena, Columbia, 2007.
    • Asche CV, McAdam-Marx C, Shane-McWhorter L, Plauschinat C. Adverse Events and Oral Antidiabetic Outcomes in a Real World Setting. American Diabetes Association (ADA), Chicago, IL, 2007.
    • Asche CV, Oderda LH, Pepper GA. The Economic Impact of Treatment of Falls- Related Injuries from a U.S. Employers Perspective. Center on Aging Research Retreat, Salt Lake City, UT, 2007.
    • LaFleur J, Asche CV, McAdam-Marx C, Alder S, Sheng X. Postmenopausal osteoporosis fracture occurrence and fracture rates by age in a primary-care setting. Utah Health Services Research Conference, VA Salt Lake City Health Care System, Salt Lake City, UT, 2007.
    • Asche CV, McAdam-Marx C, Shane-McWhorter L, Plauschinat C. Evaluation of diabetes treatment patterns and adverse events in a usual care setting. Utah Health Services Research Conference, VA Salt Lake City Health Care System, Salt Lake City, UT, 2007.
    • Seal B, Mucha L, Lenhart G, Asche CV. Incremental Costs Associated with Antibiotics Prescribed for Acute Otitis Media. 12th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, VA, 2007.
    • Mucha L, Seal B, Lenhart G, Asche CV. Direct and Incremental Costs of Acute Respiratory Infections. 12th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, VA, 2007.
    • LaFleur J, McAdam-Marx C, Asche CV, Alder S, Sheng X, Brixner DI, Silverman S. The Risk of Clinical Vertebral Fracture for Postmenopausal Patients with Specific Combinations of Fracture Risk Factors in a Primary-Care Setting. National Osteoporosis Foundation (NOF), Washington, DC, 2007.
    • Said Q, Rosenblatt LC, Ghate SR, Whitehead R, Brixner DI. Real World Impact of Second Generation Antipsychotics on Weight Gain in an Adolescent Population. 59th Institute on Psychiatric Services, New Orleans, LA, October 11-14, 2007.
    • Asche CV, Mucha L, Lenhart G, Seal B. Incremental Costs Associated Antibiotics Prescribed for Community Acquired Pneumonia Episodes. 12th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, VA, 2007.
    • Asche CV. Overview of Data used in Outcomes Research. Pharmaceutical Market Research Summit. Leverage Pre and Post Launch Market Research Strategies to Improve Initial Product Positioning and Ongoing Strategic Decision Making. King of Prussia, PA, 2006.
    • Asche CV. Improving Outcomes in the Treatment of Lower Respiratory Tract Infections. Independence of Washington State Pharmacy Association Continuing Education Seminars. Washington State Pharmacy Association (WSPA) Mid-Year Meeting. Renton, Washington, 2006.
    • Brixner DI (presenter), Joish VN, McAdam-Marx C, Arondekar B, Hoblyuk R. Evaluation of Persistency and Outcomes in Patients on SU Combination Therapy with TZD's or Metformin. 2nd Annual Health Services Research Conference. Salt Lake City, UT, 2006
    • Brixner DI. Pharmacoeconomics of COPD Management. American Society of Hospital Pharmacists Mid-year Meeting, Anaheim, CA, 2006.
    • Brixner DI. Real World Data in Healthcare Decision Making. European Science Foundation Conference on the Global Health Economy, Kiel, Germany, 2006.
    • Brixner DI. Assessment of Cardiometabolic Risk in a Primary Care Electronic Medical Database. Academy of Managed Care Pharmacy Meeting, Seattle, WA, 2006.
    • Brixner DI. Developing and Implementing Pharmacy Policy for Insomnia Therapies within Managed Care Plans. Academy of Managed Care Pharmacy Meeting, Seattle, WA, 2006.
    • Asche CV. Prospective Economic Evaluations in Clinical Trials and Examples, First Western Pharmacoeconomics Conference; Salt Lake City, Utah, 2005.
    • Asche CV. Overview of Data used in Outcomes Research. Strategic Research Institute Conference Patient Level Data for the Pharmaceutical Industry; Washington, DC, 2005.
    • Brixner DI. Assessment of the Prevalence and Costs of Osteoporosis Treatment Options in a Real World Setting. AMCP Symposium; Nashville, TN, 2005.
    • Brixner DI. The Case Against Excessive Cost Sharing for Biologics. AMCP Symposium; Nashville, TN, 2005.
    • Brixner DI. Electronic Medical Records in Outcomes Research: The New Frontier. Jefferson Medical College; Philadelphia, PA, 2005.
    • Brixner DI. Improving Outcomes in the Treatment of Lower Respiratory Tract Infections AMCP Framework on Quality Drug Therapy. AMCP Annual Meeting; Denver, CO, 2005.
    • Brixner DI. Managing Your Osteoporosis Formulary to Maximize Bone Strength and Minimize Fracture. AMCP Annual Meeting; Denver, CO, 2005.
    • Joish VN. Risk-adjustment in Outcomes Research: The Case of Diabetes Severity Index. Guest Lecture at the Ohio State University College of Pharmacy; Columbus, OH, 2005.
    • Joish VN. Application of Pharmacoeconomics in the Western World. Guest lecture to post-graduate students at Principale K.M. Kundnani College of Pharmacy; Mumbai, India, 2005.
    • Joish VN. Cost-effectiveness Analysis and Methodological Issues in Pharmacoeconomics Research. 3 day workshop at the India Gandhi Government Medical College, Nagpur, India. Workshop for members of Indian Clinical Epidemiologists Network (INDIACLEN), 2005.
    • Brixner DI, Corey-Lisle P, Oberg B, Tuomari V, Biskupiak JE. Complexity of Depression Treatments: Healthcare Utilization and Costs. APA Annual Meeting, Toronto, Canada, 2005.
    • Brixner DI, Jorgenson JA. Relationship Between Health Systems and Colleges of Pharmacy - AACP-Sponsored Program at the ASHP Midyear Clinical Meeting. 2004.
    • Brixner DI. Managing the Continuum of Treatment: Modeling the Economic Impact of Treating Diabetes. Symposium in conjunction with the Academy of Managed Care Pharmacy. 2004.
    • Joish VN. Introduction to Pharmacoeconomics and Health Outcomes Research. Seminar of pharmaceutical company sales staff at Principal K.M. Kundnani College of Pharmacy; Mumbai, India, 2004.
    • Brixner DI. Patient Management in Irritable Bowel Syndrome. American Society of Health System Pharmacists Midyear Meeting. 2003.
    • Brixner DI. The Management of COPD in Managed Care Systems. Pre- Meeting Symposium to the Academy of Managed Care Pharmacy. 2003.
    • Brixner DI. The Economics of Insomnia. Pre-Meeting Symposium to the Academy of Managed Care Pharmacy. 2003.
    • Brixner DI. Evidenced Based Treatment Approaches to Irritable Bowel Syndrome. Pre-Meeting Symposium to the Academy of Managed Care Pharmacy. 2003.
    • Brixner DI. Utilization of the AMCP Format in Medicaid, Medicaid & Medicare, the Changing Landscape. 2003.